|
1
|
Cabibbo G, Latteri F, Antonucci M and
Craxì A: Multimodal approaches to the treatment of hepatocellular
carcinoma. Nat Clin Pract Gastroenterol Hepatol. 6:159–169. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh S, Singh PP, Roberts LR and Sanchez
W: Chemopreventive strategies in hepatocellular carcinoma. Nat Rev
Gastroenterol Hepatol. 11:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dutta R and Mahato RI: Recent advances in
hepatocellular carcinoma therapy. Pharmacol Ther. 173:106–117.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu Q, Liu ZY, Chen Q and Lin JS: Mcl-1 as
a potential therapeutic target for human hepatocelluar carcinoma. J
Huazhong Univ Sci Technolog Med Sci. 36:494–500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khanna K, Mishra KP, Ganju L and Singh SB:
Golden root: A wholesome treat of immunity. Biomed Pharmacother.
87:496–502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu X, Lin S, Yu D, Qiu S, Zhang X and Mei
R: A preliminary study: The anti-proliferation effect of
salidroside on different human cancer cell lines. Cell Biol
Toxicol. 26:499–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schriner SE, Abrahamyan A, Avanessian A,
Bussel I, Maler S, Gazarian M, Holmbeck MA and Jafari M: Decreased
mitochondrial superoxide levels and enhanced protection against
paraquat in Drosophila melanogaster supplemented with Rhodiola
rosea. Free Radic Res. 43:836–843. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Yu H, Sun Y, Lin X, Chen B, Tan
C, Cao G and Wang Z: Protective effects of salidroside on hydrogen
peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells.
Eur J Pharmacol. 564:18–25. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goel HC, Bala M, Prasad J, Singh S,
Agrawala PK and Swahney RC: Radioprotection by Rhodiola
imbricata in mice against whole-body lethal irradiation. J Med
Food. 9:154–160. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Perfumi M and Mattioli L: Adaptogenic and
central nervous system effects of single doses of 3% rosavin and 1%
salidroside Rhodiola rosea L. extract in mice. Phytother
Res. 21:37–43. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spasov AA, Wikman GK, Mandrikov VB,
Mironova IA and Neumoin VV: A double-blind, placebo-controlled
pilot study of the stimulating and adaptogenic effect of
Rhodiola rosea SHR-5 extract on the fatigue of students
caused by stress during an examination period with a repeated
low-dose regimen. Phytomedicine. 7:85–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mishra KP, Padwad YS, Dutta A, Ganju L,
Sairam M, Banerjee PK and Sawhney RC: Aqueous extract of
Rhodiola imbricata rhizome inhibits proliferation of an
erythroleukemic cell line K-562 by inducing apoptosis and cell
cycle arrest at G2/M phase. Immunobiology. 213:125–131. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang DZ, Hong HD, Kim KI and Choi SY:
Anti-fatigue effects of fermented Rhodiola rosea extract in
mice. Prev Nutr Food Sci. 20:38–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tao K, Wang B, Feng D, Zhang W, Lu F, Lai
J, Huang L, Nie T and Yang Q: Salidroside protects against
6-hydroxydopamine-induced cytotoxicity by attenuating ER stress.
Neurosci Bull. 32:61–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Yao Y, Wang H, Guo Y, Zhang H and
Chen L: Effects of salidroside on glioma formation and growth
inhibition together with improvement of tumor microenvironment.
Chin J Cancer Res. 25:520–526. 2013.PubMed/NCBI
|
|
16
|
Wang H, Ding Y, Zhou J, Sun X and Wang S:
The in vitro and in vivo antiviral effects of
salidroside from Rhodiola rosea L. against coxsackievirus
B3. Phytomedicine. 16:146–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ming DS, Hillhouse BJ, Guns ES, Eberding
A, Xie S, Vimalanathan S and Towers GH: Bioactive compounds from
Rhodiola rosea (Crassulaceae). Phytother Res. 19:740–743.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Li JZ, Lu AX, Zhang KF and Li BJ:
Anticancer effect of salidroside on A549 lung cancer cells through
inhibition of oxidative stress and phospho-p38 expression. Oncol
Lett. 7:1159–1164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu X, Zhang X, Qiu S, Yu D and Lin S:
Salidroside induces cell-cycle arrest and apoptosis in human breast
cancer cells. Biochem Biophys Res Commun. 398:62–67. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fan XJ, Wang Y, Wang L and Zhu M:
Salidroside induces apoptosis and autophagy in human colorectal
cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol
Rep. 36:3559–3567. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Senthilkumar R, Parimelazhagan T,
Chaurasia OP and Srivastava RB: Free radical scavenging property
and antiproliferative activity of Rhodiola imbricata Edgew
extracts in HT-29 human colon cancer cells. Asian Pac J Trop Med.
6:11–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao G, Shi A, Fan Z and Du Y: Salidroside
inhibits the growth of human breast cancer in vitro and
in vivo. Oncol Rep. 33:2553–2560. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun C, Wang Z, Zheng Q and Zhang H:
Salidroside inhibits migration and invasion of human fibrosarcoma
HT1080 cells. Phytomedicine. 19:355–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao J, Song Z, Chen Y, Xia L, Wang J, Fan
R, Du R, Zhang F, Hong L, Song J, et al: Deregulated expression of
Notch receptors in human hepatocellular carcinoma. Dig Liver Dis.
40:114–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nicolas M, Wolfer A, Raj K, Kummer JA,
Mill P, van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F:
Notch1 functions as a tumor suppressor in mouse skin. Nat Genet.
33:416–421. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sriuranpong V, Borges MW, Ravi RK, Arnold
DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell
cycle arrest in small cell lung cancer cells. Cancer Res.
61:3200–3205. 2001.PubMed/NCBI
|
|
27
|
Jang MS, Zlobin A, Kast WM and Miele L:
Notch signaling as a target in multimodality cancer therapy. Curr
Opin Mol Ther. 2:55–65. 2000.PubMed/NCBI
|
|
28
|
Ma YC, Shi C, Zhang YN, Wang LG, Liu H,
Jia HT, Zhang YX, Sarkar FH and Wang ZS: The tyrosine kinase c-Src
directly mediates growth factor-induced Notch-1 and Furin
interaction and Notch-1 activation in pancreatic cancer cells. PloS
One. 7:e334142012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu B, Wei J, Qian X, Lei D, Ma Q and Liu
Y: Notch1 signaling pathway participates in cancer invasion by
regulating MMPs in lingual squamous cell carcinoma. Oncol Rep.
27:547–552. 2012.PubMed/NCBI
|
|
30
|
Wang J, Fu L, Gu F and Ma Y: Notch1 is
involved in migration and invasion of human breast cancer cells.
Oncol Rep. 26:1295–1303. 2011.PubMed/NCBI
|
|
31
|
Zhou L, Zhang N, Li QJ, Sun W, Zhang Y,
Wang DS and Dou KF: Associations between high levels of Notch1
expression and high invasion and poor overall survival in
hepatocellular carcinoma. Tumour Biol. 34:543–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: Downregulation of the Notch signaling pathway inhibits
hepatocellular carcinoma cell invasion by inactivation of matrix
metalloproteinase-2 and −9 and vascular endothelial growth factor.
Oncol Rep. 28:874–882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sahlgren C, Gustafsson MV, Jin S,
Poellinger L and Lendahl U: Notch signaling mediates
hypoxia-induced tumor cell migration and invasion. Proc Natl Acad
Sci USA. 105:6392–6397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu
X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin
pathway in metastatic hepatocellular carcinoma. Int J Cancer.
131:E163–E172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lim SO, Kim HS, Quan X, Ahn SM, Kim H,
Hsieh D, Seong JK and Jung G: Notch1 binds and induces degradation
of Snail in hepatocellular carcinoma. BMC Biol. 9:832011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lim SO, Park YM, Kim HS, Quan X, Yoo JE,
Park YN, Choi GH and Jung G: Notch1 differentially regulates
oncogenesis by wildtype p53 overexpression and p53 mutation in
grade III hepatocellular carcinoma. Hepatology. 53:1352–1362. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khamis ZI, Iczkowski KA and Sang QXA:
Metastasis suppressors in human benign prostate, intraepithelial
neoplasia, and invasive cancer: Their prospects as therapeutic
agents. Med Res Rev. 32:1026–1077. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Debruyne P, Vermeulen S and Mareel M: The
role of the E-cadherin/catenin complex in gastrointestinal cancer.
Acta Gastroenterol Belg. 62:393–402. 1999.PubMed/NCBI
|
|
39
|
Mareel M, Vleminckx K, Vermeulen S, Yan G,
Bracke M and van Roy F: Downregulation in vivo of the
invasion-suppressor molecule E-cadherin in experimental and
clinical cancer. Princess Takamatsu Symp. 24:63–80. 1994.PubMed/NCBI
|
|
40
|
Vihinen P and Kähäri VM: Matrix
metalloproteinases in cancer: Prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Curran S and Murray GI: Matrix
metalloproteinases: Molecular aspects of their roles in tumour
invasion and metastasis. Eur J Cancer. 36:1621–1630. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Weis M, Heeschen C, Glassford AJ and Cooke
JP: Statins have biphasic effects on angiogenesis. Circulation.
105:739–745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu HM, Zhu SL, He LJ, Liu YH and Xie D:
Clinical significance of macrophage migration inhibitory factor in
invasion of ovarian cancer. Chin J Cancer. 28:1054–1060.
2009.[Clinical significance of macrophage migration inhibitory
factor in invasion of ovarian cancer]. View Article : Google Scholar
|
|
45
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of Snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qu L and Liu B: Cyclooxygeanse-2 promotes
metastasis in osteosarcoma. Cancer Cell Int. 15:692015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wieland E, Rodriguez-Vita J, Liebler SS,
Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A,
Chang-Claude J, et al: Endothelial Notch1 activity facilitates
metastasis. Cancer Cell. 31:355–367. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Egan SE, St-Pierre B and Leow CC: Notch
receptors, partners and regulators: From conserved domains to
powerful functions. Curr Top Microbiol Immunol. 228:273–324.
1998.PubMed/NCBI
|
|
51
|
Callahan R and Egan SE: Notch signaling in
mammary development and oncogenesis. J Mammary Gland Biol
Neoplasia. 9:145–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Reedijk M, Odorcic S, Chang L, Zhang H,
Miller N, McCready DR, Lockwood G and Egan SE: High-level
coexpression of JAG1 and NOTCH1 is observed in human breast cancer
and is associated with poor overall survival. Cancer Res.
65:8530–8537. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chu D, Li Y, Wang W, Zhao Q, Li J, Lu Y,
Li M, Dong G, Zhang H, Xie H and Ji G: High level of Notch1 protein
is associated with poor overall survival in colorectal cancer. Ann
Surg Oncol. 17:1337–1342. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Makrilia N, Kollias A, Manolopoulos L and
Syrigos K: Cell adhesion molecules: Role and clinical significance
in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Mareel M, Vleminckx K, Vermeulen S, Bracke
M and Van Roy F: E-cadherin expression: A counterbalance for cancer
cell invasion. Bull Cancer. 79:347–355. 1992.PubMed/NCBI
|
|
56
|
Shimada T, Nakamura H, Yamashita K, Kawata
R, Murakami Y, Fujimoto N, Sato H, Seiki M and Okada Y: Enhanced
production and activation of progelatinase A mediated by
membrane-type 1 matrix metalloproteinase in human oral squamous
cell carcinomas: Implications for lymph node metastasis. Clin Exp
Metastasis. 18:179–188. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rajoria S, Suriano R, George A, Shanmugam
A, Schantz SP, Geliebter J and Tiwari RK: Estrogen induced
metastatic modulators MMP-2 and MMP-9 are targets of
3,3′-diindolylmethane in thyroid cancer. PLoS One. 6:e158792011.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yan L, Lin B, Gao L, Gao S, Liu C, Wang C,
Wang Y, Zhang S and Iwamori M: Lewis (y) antigen overexpression
increases the expression of MMP-2 and MMP-9 and invasion of human
ovarian cancer cells. Int J Mol Sci. 11:4441–4452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Murphy AN, Unsworth EJ and
Stetler-Stevenson WG: Tissue inhibitor of metalloproteinases-2
inhibits bFGF-induced human microvascular endothelial cell
proliferation. J Cell Physiol. 157:351–358. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhao HB, Qi SN, Dong JZ, Ha XQ, Li XY,
Zhang QW, Yang YS, Bai J and Zhao L: Salidroside induces neuronal
differentiation of mouse mesenchymal stem cells through Notch and
BMP signaling pathways. Food Chem Toxicol. 71:60–67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
